Health risks associated with non-medical use of ketamine in France: National surveillance insights from the French Addictovigilance Network, 2019–2023
These findings demonstrate a marked increase in ketamine-related complications in France, particularly among young users. Severe urinary and biliary complications, alongside rising reports of ketamine use disorder, highlight an urgent need for awareness among clinicians, systematic screening, and targeted harm reduction and clinical screening strategies.
Authors
- Salim Mezaache (ORCID: https://orcid.org/0000-0002-8396-3667)
- Thomas Soeiro (ORCID: https://orcid.org/0000-0003-2604-9673)
- Andrée Boucher (ORCID: https://orcid.org/0000-0003-2625-0086)
- Joëlle Micallef
- N. Fouilhé Sam-Laï
- Tiphaine Raingeard
- Caroline Victorri-Vigneau
- Reynald Le Boisselier
Institutions
- Inserm (FR)
- Aix-Marseille Université (FR)
- Centre Hospitalier Universitaire de Grenoble (FR)
- Centre Hospitalier Universitaire de Nantes (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hospices Civils de Lyon (FR)
- Centre Hospitalier Universitaire de Rouen (FR)
Publication Details
- Journal
- Journal of Psychopharmacology
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1177/02698811261420018
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00